1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico HIV Drug Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico HIV Drug Market Revenues & Volume, 2022 & 2032F |
3.3 Mexico HIV Drug Market - Industry Life Cycle |
3.4 Mexico HIV Drug Market - Porter's Five Forces |
3.5 Mexico HIV Drug Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.6 Mexico HIV Drug Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Mexico HIV Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HIV/AIDS in Mexico |
4.2.2 Growing awareness about HIV prevention and treatment |
4.2.3 Government initiatives to improve access to healthcare services for HIV patients |
4.3 Market Restraints |
4.3.1 High cost of HIV drugs and treatment |
4.3.2 Stigma associated with HIV/AIDS leading to underreporting and lack of treatment seeking behavior |
5 Mexico HIV Drug Market Trends |
6 Mexico HIV Drug Market, By Types |
6.1 Mexico HIV Drug Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Mexico HIV Drug Market Revenues & Volume, By Drug Class, 2022-2032F |
6.1.3 Mexico HIV Drug Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), 2022-2032F |
6.1.4 Mexico HIV Drug Market Revenues & Volume, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), 2022-2032F |
6.1.5 Mexico HIV Drug Market Revenues & Volume, By Protease Inhibitors (PIs), 2022-2032F |
6.2 Mexico HIV Drug Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Mexico HIV Drug Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.2.3 Mexico HIV Drug Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.2.4 Mexico HIV Drug Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Mexico HIV Drug Market Import-Export Trade Statistics |
7.1 Mexico HIV Drug Market Export to Major Countries |
7.2 Mexico HIV Drug Market Imports from Major Countries |
8 Mexico HIV Drug Market Key Performance Indicators |
8.1 Number of individuals newly diagnosed with HIV |
8.2 Percentage of HIV patients receiving antiretroviral therapy (ART) |
8.3 HIV testing and treatment coverage rate |
9 Mexico HIV Drug Market - Opportunity Assessment |
9.1 Mexico HIV Drug Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.2 Mexico HIV Drug Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Mexico HIV Drug Market - Competitive Landscape |
10.1 Mexico HIV Drug Market Revenue Share, By Companies, 2025 |
10.2 Mexico HIV Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |